743 Prospect Street La Jolla CA 92037 Company Announcement — ASX: HPC DATE: 23 October 2026 Non-Renounceable Pro Rata Entitlement Offer with Free-Attaching Options and Share Sale Facility Hydration solutions company The Hydration Pharmaceuticals Company Limited (ACN 620 385 677) (ASX: HPC) (the...
Rights Issue and UMP Share Sale Facility
Filed with ASX ·
6ix is reading this filing.
Hydration Pharmaceuticals Company Limited on 6ix
Story so far
Earlier from Hydration Pharmaceuticals
- July and August 2026 Trading Update
- Appendix 4D and FY26 Half Year Financial Report
- Q2 FY26 Quarterly Activities Report (App 4C)
- Capital raising, board renewal and management changes
- Q1 FY26 Quarterly Activities Report (App 4C)
Later from Hydration Pharmaceuticals
All Hydration Pharmaceuticals news releasesFollow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals